Casandra
Casandra Test Code AR31955Version 1 (DRAFT)
Performing Lab
Dermatomyositis and Polymyositis Panel
Also known as: COMBI PAN
Clinical Use
Order TestUse
May be useful for the evaluation of patients with progressive proximal muscle weakness and/or cutaneous manifestations suggestive of dermatomyositis and/or associated connective tissue disease.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
New York Approved
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
14 targets
Antinuclear Antibody (ANA), HEp-2, IgGEJ (glycyl-tRNA synthetase) AntibodyJo-1 (Histidyl-tRNA Synthetase) Ab, IgGMDA5 (CADM-140) AbMi-2 (nuclear helicase protein) AntibodyNXP2 (Nuclear matrix protein-2) AbOJ (isoleucyl-tRNA synthetase) AntibodyP155/140 Antibody+6 more
Result Turnaround Time
7-18 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
4 mL to ARUP standard transport tube
Minimum Volume
3 mL
Container
Serum separator tube (SST)
Collection Instructions
Separate from cells ASAP or within 2 hours of collection
Causes for Rejection
Hemolyzed, hyperlipemic, icteric, heat‑treated, or contaminated specimens
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 month |
Related Tests
Other tests from different labs that may be relevant
MyoMarker 3 Plus Profile
Mayo Clinic Lab
MyoMarker 3 Profile
Mayo Clinic Lab
MyoMarker® 3 Plus Profile (RDL)
Labcorp
Extended Myositis Specific Antibody (MSA) Panel
Quest Diagnostics
Jo-1 Antibody
Quest Diagnostics
Anti-MDA-5 Ab (CADM-140)
Mayo Clinic Lab
Anti-Jo-1
Labcorp
Myositis Specific 11 Antibody Panel
Quest Diagnostics
Anti-MDA-5 Ab (CADM-140) (RDL)
Labcorp
Anti-TIF-1gamma Ab (RDL)
Labcorp